BioNTech CEO Ugur Sahin disposes of $5,935,923 of common shares
Bitget2026/10/09 20:47BioNTech CEO Ugur Sahin disclosed sales of ordinary shares on Oct. 8-9, 2026. Disposed of 63,209 shares at USD 92.3142 to USD 95.3733. Directly held ordinary shares fell to zero following the transactions. Continued to report 39,218,111 ordinary shares held indirectly. Trades were executed under a Rule 10b5-1 plan adopted on June 3, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000035), on October 09, 2026, and is solely responsible for the information contained therein.
- BioNTech CEO Ugur Sahin disclosed sales of ordinary shares on Oct. 8-9, 2026.
- Disposed of 63,209 shares at USD 92.3142 to USD 95.3733.
- Directly held ordinary shares fell to zero following the transactions.
- Continued to report 39,218,111 ordinary shares held indirectly.
- Trades were executed under a Rule 10b5-1 plan adopted on June 3, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BMO raises target price for cybersecurity stocks
Needham raises CrowdStrike target price to $310
Morgan Stanley raises CME Group price target to $337